Urticaria is an inflammatory skin disorder that affects up to 20% of the world population at
some point during their life. It presents with wheals, angioedema or both due to activation …

These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP),
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …

This update and revision of the international guideline for urticaria was developed following
the methods recommended by Cochrane and the Grading of Recommendations …

This evidence‐and consensus‐based guideline was developed following the methods
recommended by Cochrane and the Grading of Recommendations Assessment …

This guideline is the result of a systematic literature review using the 'G rading of R
ecommendations A ssessment, D evelopment and E valuation'(GRADE) methodology and a …

Chronic spontaneous urticaria (CSU) is a mast cell–driven skin disease characterized by the
recurrence of transient wheals, angioedema, or both for more than 6 weeks. Autoimmunity is …

This update on chronic urticaria (CU) focuses on the prevalence and pathogenesis of
chronic spontaneous urticaria (CSU), the expanding spectrum of patient-reported outcome …

To cite this article: Maurer M, Weller K, Bindslev‐Jensen C, Giménez‐Arnau A, Bousquet PJ,
Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CEH, Greaves MW, Hide M …

The current therapeutic algorithm for chronic spontaneous urticaria (CSU), endorsed by the
international guideline, entails treatment escalation from second‐generation H1 …

This guidance for the management of patients with chronic urticaria and angioedema has
been prepared by the Standards of Care Committee of the British Society for Allergy and …